CRK Rises 3.7%: Perfect Valuation Score Mask Weak Growth, Finances

CRK shares rose 3.7% to $14. Despite a GF Value estimate suggesting modest undervaluation, the GF Score reveals weak growth and financial strength. Insiders sold without any buying.
COMSTOCK RESOURCES INC currently carries an Alpha Score of n/a, giving AlphaScala's model a neutral read on the setup.
Comstock Resources (CRK) shares closed at $14.00 on October 16, up 3.7% on the session. The gain does little to reverse a deeper slide: the stock is down 39.6% year to date and 21% over the past year. Its 52-week range runs from $12.12 to $28.10.
The GF Value estimate, a proprietary measure blending historical multiples, past growth, and forward expectations, puts intrinsic value at $16.00. The current price sits 12.5% below that figure, a gap that could signal modest undervaluation. GuruFocus data shows CRK has been unprofitable and cash-flow negative, weakening the weight that earnings-based valuation tools typically carry.
CRK's price-to-earnings ratio stands at 8.1x, slightly above the five-year median of 7.8x. On a historical P/E basis, the stock is not obviously cheap.
GuruFocus assigns CRK a composite GF Score of 66 out of 100, a rating described as Above Average. The components tell a split story. Valuation scored a perfect 10/10. Growth scored 2/10, financial strength 3/10. Further details on the score breakdown and underlying data are available on the CRK stock page.
Insider activity over the past 12 months adds a cautionary note. Insiders sold $1.0 million worth of shares and bought none, according to GuruFocus data. Professional investor positions show a mixed picture: three gurus hold the stock, with three adding and two trimming in recent quarters.
The stock closed at $14.00, near the lower end of its 52-week range and 26.5% below the high of $28.10 reached over the past year.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.